Expression and prognostic significance of lysozyme in male breast cancer

Breast Cancer Research

Volumn 4, Issue 6, 2002, Pages

  Serra, Carlos ^a   Vizoso, Francisco ^b   Alonso, Lorena ^b   Rodríguez, Juan C ^b   González, Luis O ^b   Fernández, María ^c   Lamelas, María L ^d   Sánchez, Luis M ^c   García Muñiz, José L ^e   Baltasar, Aniceto ^a   Medrano, Justo ^f  

^a HOSPITAL VIRGEN DE LOS LIRIOS   (Spain)

^b Hospital de Jove Gijón Asturias España   (Spain)

^c UNIVERSITY OF OVIEDO   (Spain)

^d Servicio de Ginecologíadel Hospital de Jove de Gijón   (Spain)

^e HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^f MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

Lysozyme; Male breast cancer; Prognosis; Prolactin receptors

Indexed keywords

ESTROGEN RECEPTOR; LYSOZYME; TUMOR MARKER;

ADULT; AGE; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER SIZE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; GYNECOMASTIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MALE BREAST CANCER; METASTASIS; OVERALL SURVIVAL; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SHORT TERM SURVIVAL; TISSUE SECTION; AGED; BREAST TUMOR; ENZYMOLOGY; MIDDLE AGED; MORTALITY; SURVIVAL RATE;

ADULT; AGED; BREAST NEOPLASMS, MALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MURAMIDASE; SURVIVAL RATE;

EID: 63049101059     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr537     Document Type: Article

References (34)

1. Crichlow RW, Galt SW: Male breast cancer. Surg Clin North Am. 1990, 70: 1165-1177.
2. Adami HL, Haulinen T, Ewetz M: The survival pattern in male breast cancer: an analysis of 1429 patients from the Nordic countries. Cancer. 1989, 64: 1177-1182.
3. Heller KS, Rosen PP, Schottenfeld D: Male breast cancer: a clinicopathologic study of 97 cases. Ann Surg. 1978, 188: 60-65.
4. Appelqvist P, Salmo M: Prognosis of carcinoma of the male breast. Acta Chir Scand. 1982, 148: 499-502.
5. Ciatto S, Iossa A, Bonardi R: Male breast carcinoma: review of a multicenter series of 150 cases. Tumori. 1990, 76: 555-558.
6. Salvadori B, Saccozzi R, Manzari A, Andreola S, Conti RA, Cusumano F, Grassi M: Prognosis of breast cancer in males: an analysis of 170 cases. Eur J Cancer. 1994, 30: 930-935.
7. Fleming A: On a remarkable bacteriolitic element found in tissues and secretions. Proc Roy Soc London. 1922, B93: 306-317.
8. Petrakis NL: Physiologic, biochemical and cytologic aspects of the nipple aspirate fluid. Breast Cancer Res Treat. 1986, 8: 7-19.
9. Biggar WD, Sturgess JM: Role of lysozyme in the microbicidal activity of rat alveolar macrophages. Infection Immunol. 1977, 16: 974-982.
10. Klokars ML, Robers P: Stimulation of phagocytosis by human lysozyme. Acta Haematol. 1976, 52: 289-295.
11. Sánchez LM, Vizoso F, Díez-Itza I, López-Otín C: Identification of the major protein components in breast secretions from women with benign and malignant breast diseases. Cancer Res. 1992, 52: 95-100.
12. Vizoso F, Sánchez LM, Díez-Itza I, Lamelas ML, López-Otín C: Factors affecting protein composition of breast secretions from nonlactating women. Breast Cancer Res Treat. 1992, 23: 251-258.
13. Vizoso F, Díez-Itza I, Sánchez LM, Ruibal A, López-Otín C: Relationship between prolactin levels and composition of breast secretions in nonlactating women. J Clin Endocinol Metab. 1994, 79: 525-529.
14. Vizoso F, Plaza E, Vázquez J, Serra C, Lamelas ML, González LO, Merino AM, Méndez J: Lysozyme expression by breast carcinomas, correlation with clinicopathologic parameters, and prognostic significance. Ann Surg Oncol. 2001, 8: 667-674. 10.1245/aso.2001.8.8.667.
15. Serra C, Vizoso F, Rodriguez JC, Merino AM, González LO, Baltasar A, Pérez-Vázquez MT, Medrano J: Expression of pepsinogen C in gynecomastias and male breast carcinomas. World J Surg. 1999, 23: 439-445.
16. Serra C, Vizoso F, Lamelas ML, Rodríguez JC, González LO, Baltasar A, Medrano J: Expression and clinical significance of apolipoprotein D in male breast cancer and gynaecomastia. Br J Surg. 1999, 86: 1190-1197. 10.1046/j.1365-2168.1999.01157.x.
17. Serra C, Vizoso F, Lamelas ML, Rodríguez JC, González LO, Merino AM, Baltasar A, Pérez-Vázquez MT, Medrano J: Comparative study of two androgen-induced (Apolipoprotein D and Pepsinogen C) prognostic markers between female and male breast carcinoma. Int J Surg Invest. 2000, 2: 183-192.
18. Weber-Chappuis K, Bieri-Burger S, Hurliman J: Comparison of prognostic markers detected by immunohistochemistry in male and female breast carcinomas. Eur J Cancer. 1996, 32: 1686-1692. 10.1016/0959-8049(96)00154-2.
19. Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer. Br J Cancer. 1957, 11: 359-377.
20. Vaitukaitis JL: Production of antisera with small doses of immunogen: multiple intradermal injections. Methods Enzymol. 1981, 73: 46-52.
21. Laemmili UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970, 227: 680-685.
22. McCarty KS, Szabo E, Flowers JL, Cox EB, Leight GS, Miller L, Konrath J, Soper JT, Budwit DA, Creasman WT: Use of a monoclonal anti-estrogen receptor antibody in the inmunohistochemical evaluation of human tumors. Cancer Res. 1986, 46: 4244-4248.
23. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958, 53: 457-481.
24. Mantel M, Myers M: Problems of convergence of maximum likelihood iterative procedures in muliparameter situations. J Am Stat Assoc. 1971, 66: 484-491.
25. Cox DR: Regression models and life tables. J R Stat Soc B. 1972, 34: 187-220.
26. Dixon WJ, Brown MB, Engelman L, Frane JW, Hill MA, Jennrich RI: BMDP statistical software. 1985, Berkeley: University of California Press
27. Topper YJ, Freeman CS: Multiple hormone interactions in the developmental biology of the mammary gland. Physiol Rev. 1989, 60: 1049-1106.
28. Ginsburg E, Vonderhaar BK: Prolactin synthesis and secretion by human breast cancer cells. Cancer Res. 1995, 55: 2591-2595.
29. Holdaway MI, Friesen HG: Hormone binding by human mammary carcinoma. Cancer Res. 1977, 37: 1946-1952.
30. Partridge RK, Hahnel R: Prolactin receptors in human breast carcinoma. Cancer. 1979, 43: 643-646.
31. Turcot Lemay L, Kelly PA: Prolactin in human breast tumors. J Natl Cancer Inst. 1982, 68: 381-383.
32. Bonneterre J, Peurat JP, Vandewalle B, BeuscartT R, Vie MC, Cappelaere P: Prolactin receptors in human breast cancer. Eur J Cancer. 1982, 18: 1157-1162.
33. Touraine F, Martini JF, Zafrani B, Durand JC, Labaille F, Malet C, Nicolas A, Triven C, Postel-Vinay MC, Kutten F, Kelly PA: Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues. J Clin Endocrinol Met. 1998, 83: 667-674.
34. Peyrat JP, Djiane J, Bonneterre J, Vandewalle B, Vennini PH, Delobelle A, Depadt G, Lefebvre J: Stimulation of DNA synthesis by prolactin in human breast tumor explants. Relation to prolactin receptors. Anticancer Res. 1984, 4: 257-262.